๐Ÿ“… Interviews will be scheduled via Zoom at a convenient time and last about 45 minutes.
๐Ÿ’ป Patients will receive the questions in advance and can participate using a computer, tablet, or smartphone.
๐ŸŽ A $200 Amazon e-gift card will be provided as a thank-you.
๐Ÿ“ Responses are due by November 21st.

๐Ÿ‘‰ If you or someone you know fits either description, please fill out this form to participate:
๐Ÿ”— https://docs.google.com/forms/d/e/1FAIpQLSdjIaE-OJo5QWhMYAA_9mNAUPC7BYjlkFE-UhLwBvUCl6LQjw/viewform

#CancerEducation #PatientVoices #SkinCancer #ResearchParticipation

GRACE and Medlive Patient Speaker Application

Thank you for your interest in participating in this educational program! If you are chosen, you will be provided the interview questions in advance. As a token of gratitude for participation, you will receive a $200 e-gift card for Amazon.

Google Docs

๐Ÿ‘‹ It's day 2 of our #PatientsInResearch week & we're focusing on co-creation & integrating #PatientVoices into #HealthResearch to transform results.

๐Ÿฉธ Ken Tait is contributing to research into low-sugar (hypoglycaemic) events experienced by diabetes patients as part of the Hypo-RESOLVE project. He says patients need to be at the โค๏ธ of research, co-designing and co-creating it.

๐Ÿ’ก Find out more in our health spotlight: https://europa.eu/!MmdM9H

#NothingForUsWithoutUs #PatientCentricity

๐ŸŒ ๐—ฅ๐—ฎ๐—ฟ๐—ฒ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ ๐——๐—ฎ๐˜† ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ: ๐— ๐—ผ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฎ๐—ป ๐˜†๐—ผ๐˜‚ ๐—ฐ๐—ฎ๐—ป ๐—ถ๐—บ๐—ฎ๐—ด๐—ถ๐—ป๐—ฒ; ๐—ฎ๐—ป ๐—ฎ๐—ป๐˜๐—ต๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ผ๐—ณ ๐—ฟ๐—ฎ๐—ฟ๐—ฒ ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ๐˜€ ๐ŸŒ

Today, on February 28, we come together globally to shine a light on the unique challenges faced by individuals living with rare diseases. This year's theme calls us to listen to the untold stories and resilience of patients and their families. Together, we can advocate for better support systems, foster innovation in research, and create a brighter future for those affected by these conditions worldwide.

Did you know that according to the World Health Organization (WHO), a disease is considered rare if it affects fewer than 6.5-10 people per 10,000? With millions affected worldwide, awareness is essential. Conditions like Acanthocytosis Chorea, Acute Lymphoblastic Leukaemia, and Alkaptonuria impact lives in profound ways across the globe.

๐Ÿ’ช Letโ€™s amplify their voices and turn awareness into action! Together, we can provide hope and support to countless individuals battling rare diseases around the world.

Join us in this important global movement!

#RareDiseaseDay #RareDiseases #MoreThanYouCanImagine #GlobalAwareness #Support #Advocacy #Research #HealthCare #PatientVoices #SCABPharmacy

Letโ€™s unite and make a difference today! ๐ŸŒŸ

โ€œWeโ€™re drowning and weโ€™re aloneโ€: a qualitative study of the lived experience of people experiencing persistent post-COVID-19 symptoms

https://www.cmajopen.ca/content/11/3/E504

#COVID #LongCovid #PostCovid #PatientVoices #Research

โ€œWeโ€™re drowning and weโ€™re aloneโ€: a qualitative study of the lived experience of people experiencing persistent post-COVID-19 symptoms

Background The โ€œlong tailโ€ of the COVID-19 pandemic will be reflected in disabling symptoms that persist, fluctuate or recur for extended periods for an estimated 20%โ€“30% of those who had a SARS-CoV-2 infection; development of effective interventions to address these symptoms must account for the realities faced by these patients. We sought to describe the lived experience of patients living with persistent post-COVID-19 symptoms. Methods We conducted a qualitative study, using interpretive description, of the lived experiences of adults experiencing persistent post-COVID-19 symptoms. We collected data from in-depth, semistructured virtual focus groups in February and March 2022. We used thematic analysis to analyze the data and met with several participants twice for respondent validation. Results The study included 41 participants (28 females) from across Canada with a mean age of 47.9 years and mean time since initial SARS-CoV-2 infection of 15.8 months. Four overarching themes were identified: the unique burdens of living with persistent post-COVID-19 symptoms; the complex nature of patient work in managing symptoms and seeking treatment during recovery; erosion of trust in the health care system; and the process of adaptation, which included taking charge and transformed self-identity. Interpretation Living with persistent post-COVID-19 symptoms within a health care system ill-equipped to provide needed resources profoundly challenges the ability of survivors to restore their well-being. Whereas policy and practice increasingly emphasize the importance of self-management within the context of post-COVID-19 symptoms, new investments that enhance services and support patient capacity are required to promote better outcomes for patients, the health care system and society.

CMAJ Open